Found: 948
Select item for more details and to access through your institution.
Treatment of Relapsed/Refractory Acute Myeloid Leukemia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Imatinib mesylate in the treatment of chronic myelogenous leukemia.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Maxillary Sinus Augmentation with Autogenous Tooth Grafting Material: A Systematic Review.
- Published in:
- Biomimetics (2313-7673), 2024, v. 9, n. 9, p. 518, doi. 10.3390/biomimetics9090518
- By:
- Publication type:
- Article
The Nucleolus and Its Interactions with Viral Proteins Required for Successful Infection.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 18, p. 1591, doi. 10.3390/cells13181591
- By:
- Publication type:
- Article
Flaw Detection on Surface-treated Steels Using Convolutional Neural Networks (CNN).
- Published in:
- Microscopy & Microanalysis, 2024, v. 30, p. 1, doi. 10.1093/mam/ozae044.209
- By:
- Publication type:
- Article
Comparison of PLA and ABS properties with Different Infill Percentages at 40%, 80% and 100%.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Analysis of surface on machinery grade steel Boriding.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Hardened AISI 4140 Steel Subjected to Hydrogen.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
Hardened AISI 4140 Steel Subjected to Hydrogen.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
Ponatinib after failure of second‐generation tyrosine kinase inhibitor in resistant chronic‐phase chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1419, doi. 10.1002/ajh.26686
- By:
- Publication type:
- Article
Treatment‐free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitors.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. 856, doi. 10.1002/ajh.26550
- By:
- Publication type:
- Article
Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. 1000, doi. 10.1002/ajh.26238
- By:
- Publication type:
- Article
Determination of fitness and therapeutic options in older patients with acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 4, p. 493, doi. 10.1002/ajh.26079
- By:
- Publication type:
- Article
Phase 1 study of combinatorial sorafenib, G‐CSF, and plerixafor treatment in relapsed/refractory, FLT3‐ITD‐mutated acute myelogenous leukemia patients.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 11, p. 1296, doi. 10.1002/ajh.25943
- By:
- Publication type:
- Article
Phase I/II study of dasatinib in combination with decitabine in patients with accelerated or blast phase chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 11, p. 1288, doi. 10.1002/ajh.25939
- By:
- Publication type:
- Article
The clinical impact of time to response in de novo accelerated‐phase chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. 1127, doi. 10.1002/ajh.25907
- By:
- Publication type:
- Article
Outcomes of acute myeloid leukemia with myelodysplasia related changes depend on diagnostic criteria and therapy.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 6, p. 612, doi. 10.1002/ajh.25769
- By:
- Publication type:
- Article
A heavy metal baseline score predicts outcome in acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 4, p. 422, doi. 10.1002/ajh.25731
- By:
- Publication type:
- Article
The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia‐negative B‐cell acute lymphoblastic leukemia is a strong predictor for survival.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 2, p. 144, doi. 10.1002/ajh.25671
- By:
- Publication type:
- Article
Philadelphia chromosome‐positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitors.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 12, p. 1388, doi. 10.1002/ajh.25648
- By:
- Publication type:
- Article
Philadelphia chromosome‐negative acute leukemia in patients with chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 10, p. E256, doi. 10.1002/ajh.25571
- By:
- Publication type:
- Article
Intensive chemotherapy is more effective than hypomethylating agents for the treatment of younger patients with myelodysplastic syndrome and elevated bone marrow blasts.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 7, p. E188, doi. 10.1002/ajh.25490
- By:
- Publication type:
- Article
NPM1 mutant variant allele frequency correlates with leukemia burden but does not provide prognostic information in NPM1‐mutated acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 6, p. E158, doi. 10.1002/ajh.25454
- By:
- Publication type:
- Article
Treatment‐free remission with first‐ and second‐generation tyrosine kinase inhibitors.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 3, p. 346, doi. 10.1002/ajh.25342
- By:
- Publication type:
- Article
Tyrosine kinase inhibitor interruptions, discontinuations and switching in patients with chronic‐phase chronic myeloid leukemia in routine clinical practice: SIMPLICITY.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 1, p. 46, doi. 10.1002/ajh.25306
- By:
- Publication type:
- Article
Prognostic significance of hyperdiploidy in adult acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 11, p. E357, doi. 10.1002/ajh.25240
- By:
- Publication type:
- Article
Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high‐risk MDS: Phase 2 study results.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 11, p. 1301, doi. 10.1002/ajh.25238
- By:
- Publication type:
- Article
Sorafenib Combined with 5‐azacytidine in Older Patients with Untreated FLT3‐ITD Mutated Acute Myeloid Leukemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 9, p. 1136, doi. 10.1002/ajh.25198
- By:
- Publication type:
- Article
Clinical experience with the BCL2‐inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 3, p. 401, doi. 10.1002/ajh.25000
- By:
- Publication type:
- Article
Outcome of patients with relapsed/refractory acute lymphoblastic leukemia after blinatumomab failure: No change in the level of CD19 expression.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 3, p. 371, doi. 10.1002/ajh.24987
- By:
- Publication type:
- Article
Phase 1 study of quizartinib in combination with induction and consolidation chemotherapy in patients with newly diagnosed acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. 213, doi. 10.1002/ajh.24974
- By:
- Publication type:
- Article
A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. 277, doi. 10.1002/ajh.24972
- By:
- Publication type:
- Article
Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 1, p. 84, doi. 10.1002/ajh.24943
- By:
- Publication type:
- Article
Clinical outcomes in adult patients with aplastic anemia: A single institution experience.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 12, p. 1295, doi. 10.1002/ajh.24897
- By:
- Publication type:
- Article
First-line treatment selection and early monitoring patterns in chronic phase-chronic myeloid leukemia in routine clinical practice: SIMPLICITY.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 11, p. 1214, doi. 10.1002/ajh.24887
- By:
- Publication type:
- Article
Clinical characteristics and outcomes of previously untreated patients with adult onset T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma with hyper-CVAD based regimens.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 10, p. E595, doi. 10.1002/ajh.24833
- By:
- Publication type:
- Article
Factors associated with risk of central nervous system relapse in patients with non-core binding factor acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 9, p. 924, doi. 10.1002/ajh.24799
- By:
- Publication type:
- Article
Minimal residual disease eradication with epigenetic therapy in core binding factor acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 9, p. 845, doi. 10.1002/ajh.24782
- By:
- Publication type:
- Article
Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 7, p. 599, doi. 10.1002/ajh.24735
- By:
- Publication type:
- Article
Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 6, p. E114, doi. 10.1002/ajh.24720
- By:
- Publication type:
- Article
Impact of achievement of complete cytogenetic response on outcome in patients with myelodysplastic syndromes treated with hypomethylating agents.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 4, p. 351, doi. 10.1002/ajh.24650
- By:
- Publication type:
- Article
Relapse risk and survival in patients with FLT3 mutated acute myeloid leukemia undergoing stem cell transplantation.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 4, p. 331, doi. 10.1002/ajh.24632
- By:
- Publication type:
- Article
Significance of recurrence of minimal residual disease detected by multi-parameter flow cytometry in patients with acute lymphoblastic leukemia in morphological remission.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 3, p. 279, doi. 10.1002/ajh.24629
- By:
- Publication type:
- Article
Poor outcomes associated with +der(22)t(9;22) and −9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 3, p. 238, doi. 10.1002/ajh.24625
- By:
- Publication type:
- Article
Buparlisib, a PI3K inhibitor, demonstrates acceptable tolerability and preliminary activity in a phase I trial of patients with advanced leukemias.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 1, p. 7, doi. 10.1002/ajh.24568
- By:
- Publication type:
- Article
Clinical characteristics of Philadelphia positive T-cell lymphoid leukemias-(De novo and blast phase CML).
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 1, p. E3, doi. 10.1002/ajh.24579
- By:
- Publication type:
- Article
Peripheral blood blast clearance is an independent prognostic factor for survival and response to acute myeloid leukemia induction chemotherapy.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 12, p. 1221, doi. 10.1002/ajh.24500
- By:
- Publication type:
- Article
Long-term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 12, p. 1206, doi. 10.1002/ajh.24536
- By:
- Publication type:
- Article
Dasatinib in imatinib-resistant or -intolerant chronic-phase, chronic myeloid leukemia patients: 7-year follow-up of study CA180-034.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 9, p. 869, doi. 10.1002/ajh.24423
- By:
- Publication type:
- Article
Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin-Frankfurt-Münster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 8, p. 819, doi. 10.1002/ajh.24419
- By:
- Publication type:
- Article